{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:58:14Z","timestamp":1792792694092,"version":"4.5.0"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10741-021-10171-0","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T20:02:49Z","timestamp":1631995369000},"page":"725-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The protective effects of 17-\u03b2 estradiol and SIRT1 against cardiac hypertrophy: a review"],"prefix":"10.1007","volume":"27","author":[{"given":"Zahra","family":"Hajializadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Khaksari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"2","key":"10171_CR1","first-page":"223","volume":"52","author":"M Patrizio","year":"2016","unstructured":"Patrizio M, Marano G (2016) Gender differences in cardiac hypertrophic remodeling. Ann Ist Super Sanita 52(2):223\u2013229","journal-title":"Ann Ist Super Sanita"},{"key":"10171_CR2","doi-asserted-by":"crossref","unstructured":"Di Minno A, Stornaiuolo M, Novellino\u00a0E (2019)\u00a0Molecular Scavengers, Oxidative Stress and Cardiovascular Disease. J Clin Med\u00a08(11)","DOI":"10.3390\/jcm8111895"},{"issue":"4","key":"10171_CR3","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/JME-16-0086","volume":"57","author":"L Zhou","year":"2016","unstructured":"Zhou L, Ma B, Han X (2016) The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy. J Mol Endocrinol 57(4):R143-r152","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"10171_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","volume":"34","author":"JR McMullen","year":"2007","unstructured":"McMullen JR, Jennings GL (2007) Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34(4):255\u2013262","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"10171_CR5","doi-asserted-by":"publisher","first-page":"H8","DOI":"10.1152\/ajpheart.01303.2004","volume":"289","author":"K Berenji","year":"2005","unstructured":"Berenji K et al (2005) Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 289(1):H8-h16","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10171_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.107.098046","volume":"51","author":"D Frank","year":"2008","unstructured":"Frank D et al (2008) Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 51(2):309\u2013318","journal-title":"Hypertension"},{"key":"10171_CR7","doi-asserted-by":"crossref","unstructured":"Weeks KL, McMullen JR (2011)\u00a0The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes? Physiology (Bethesda)\u00a026(2):97\u2013105","DOI":"10.1152\/physiol.00043.2010"},{"issue":"1","key":"10171_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.pharmthera.2010.04.005","volume":"128","author":"BC Bernardo","year":"2010","unstructured":"Bernardo BC et al (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 128(1):191\u2013227","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10171_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1172\/JCI25397","volume":"116","author":"C Perrino","year":"2006","unstructured":"Perrino C et al (2006) Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116(6):1547\u20131560","journal-title":"J Clin Invest"},{"issue":"8","key":"10171_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","volume":"116","author":"RC Lyon","year":"2015","unstructured":"Lyon RC et al (2015) Mechanotransduction in cardiac hypertrophy and failure. Circ Res 116(8):1462\u20131476","journal-title":"Circ Res"},{"key":"10171_CR11","unstructured":"Francis GS, McDonald KM, Cohn\u00a0JN (1993) Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention. Circulation\u00a087(5 Suppl):Iv90\u20136"},{"issue":"1","key":"10171_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrm3495","volume":"14","author":"M Maillet","year":"2013","unstructured":"Maillet M, van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14(1):38\u201348","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"10171_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","volume":"131","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella GG, Hill JA (2015) Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation 131(16):1435\u20131447","journal-title":"Circulation"},{"issue":"2","key":"10171_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jacc.2010.10.069","volume":"58","author":"DE Selby","year":"2011","unstructured":"Selby DE et al (2011) Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 58(2):147\u2013154","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10171_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7(8):589\u2013600","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10171_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T (2016) Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol 97:245\u2013262","journal-title":"J Mol Cell Cardiol"},{"key":"10171_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.lfs.2018.11.055","volume":"217","author":"WX Zhang","year":"2019","unstructured":"Zhang WX et al (2019) Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. Life Sci 217:8\u201315","journal-title":"Life Sci"},{"key":"10171_CR18","doi-asserted-by":"publisher","first-page":"5853238","DOI":"10.1155\/2017\/5853238","volume":"2017","author":"N Garc\u00eda","year":"2017","unstructured":"Garc\u00eda N, Zazueta C, Aguilera-Aguirre L (2017) Oxidative Stress and Inflammation in Cardiovascular Disease. Oxid Med Cell Longev 2017:5853238","journal-title":"Oxid Med Cell Longev"},{"key":"10171_CR19","doi-asserted-by":"crossref","unstructured":"Coelingh Bennink HJT et al (2017) Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study. Menopause\u00a024(6):677\u2013685","DOI":"10.1097\/GME.0000000000000823"},{"issue":"3\u20135","key":"10171_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER (2003) Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86(3\u20135):225\u2013230","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"10171_CR21","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1210\/en.2007-1593","volume":"149","author":"R Sirianni","year":"2008","unstructured":"Sirianni R et al (2008) The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line. Endocrinology 149(10):5043\u20135051","journal-title":"Endocrinology"},{"key":"10171_CR22","doi-asserted-by":"crossref","unstructured":"Amirkhosravi L et al (2021) E2-BSA and G1 exert neuroprotective effects and improve behavioral abnormalities following traumatic brain injury: The role of classic and non-classic estrogen receptors. Brain Res\u00a01750:147168","DOI":"10.1016\/j.brainres.2020.147168"},{"issue":"3","key":"10171_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.tcm.2010.05.001","volume":"20","author":"AM Deschamps","year":"2010","unstructured":"Deschamps AM, Murphy E, Sun J (2010) Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc Med 20(3):73\u201378","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"10171_CR24","doi-asserted-by":"publisher","first-page":"H16","DOI":"10.1152\/ajpheart.00588.2009","volume":"298","author":"JC Bopassa","year":"2010","unstructured":"Bopassa JC et al (2010) A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298(1):H16-23","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10171_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/01.CIR.0000105682.85732.BD","volume":"109","author":"FA Babiker","year":"2004","unstructured":"Babiker FA et al (2004) 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine\/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation 109(2):269\u2013276","journal-title":"Circulation"},{"issue":"1","key":"10171_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0014-5793(97)01179-4","volume":"416","author":"C Groh\u00e9","year":"1997","unstructured":"Groh\u00e9 C et al (1997) Cardiac myocytes and fibroblasts contain functional estrogen receptors. FEBS Lett 416(1):107\u2013112","journal-title":"FEBS Lett"},{"key":"10171_CR27","doi-asserted-by":"crossref","unstructured":"Darvishzadeh Mahani F, Khaksari M, Raji-Amirhasani A (2021)\u00a0Renoprotective effects of estrogen on acute kidney injury: the role of SIRT1. Int Urol Nephrol","DOI":"10.1007\/s11255-020-02761-y"},{"issue":"3","key":"10171_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/13543770902755111","volume":"19","author":"FJ Alca\u00edn","year":"2009","unstructured":"Alca\u00edn FJ, Villalba JM (2009) Sirtuin inhibitors. Expert Opin Ther Pat 19(3):283\u2013294","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10171_CR29","first-page":"59","volume":"17","author":"S Voelter-Mahlknecht","year":"2006","unstructured":"Voelter-Mahlknecht S, Mahlknecht U (2006) Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med 17(1):59\u201367","journal-title":"Int J Mol Med"},{"issue":"10\u201312","key":"10171_CR30","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbagrm.2010.06.003","volume":"1799","author":"M Lawson","year":"2010","unstructured":"Lawson M et al (2010) Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins). Biochim Biophys Acta 1799(10\u201312):726\u2013739","journal-title":"Biochim Biophys Acta"},{"issue":"7255","key":"10171_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel T, Deng CX, Mostoslavsky R (2009) Recent progress in the biology and physiology of sirtuins. Nature 460(7255):587\u2013591","journal-title":"Nature"},{"key":"10171_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2014.10.036","volume":"440","author":"L Ma","year":"2015","unstructured":"Ma L, Li Y (2015) SIRT1: role in cardiovascular biology. Clin Chim Acta 440:8\u201315","journal-title":"Clin Chim Acta"},{"issue":"5666","key":"10171_CR33","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A et al (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303(5666):2011\u20132015","journal-title":"Science"},{"issue":"7029","key":"10171_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT et al (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113\u2013118","journal-title":"Nature"},{"issue":"2","key":"10171_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00424-019-02311-1","volume":"472","author":"SG Darband","year":"2020","unstructured":"Darband SG et al (2020) Combination of exercise training and L-arginine reverses aging process through suppression of oxidative stress, inflammation, and apoptosis in the rat heart. Pflugers Arch 472(2):169\u2013178","journal-title":"Pflugers Arch"},{"issue":"10","key":"10171_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/GME.0b013e3182874732","volume":"20","author":"X Zhu","year":"2013","unstructured":"Zhu X et al (2013) Estrogens increase cystathionine-\u03b3-lyase expression and decrease inflammation and oxidative stress in the myocardium of ovariectomized rats. Menopause 20(10):1084\u20131091","journal-title":"Menopause"},{"issue":"6","key":"10171_CR37","doi-asserted-by":"publisher","first-page":"R1597","DOI":"10.1152\/ajpregu.00825.2009","volume":"298","author":"D Fliegner","year":"2010","unstructured":"Fliegner D et al (2010) Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload. Am J Physiol Regul Integr Comp Physiol 298(6):R1597\u2013R1606","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"10171_CR38","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/ERC-14-0448","volume":"22","author":"VC Jordan","year":"2015","unstructured":"Jordan VC (2015) The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer. Endocr Relat Cancer 22(1):R1-31","journal-title":"Endocr Relat Cancer"},{"key":"10171_CR39","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1100\/2011\/806787","volume":"11","author":"A Macci\u00f2","year":"2011","unstructured":"Macci\u00f2 A, Madeddu C (2011) Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Sci World J 11:2020\u20132036","journal-title":"Sci World J"},{"issue":"2","key":"10171_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tem.2004.01.005","volume":"15","author":"S St\u00f6rk","year":"2004","unstructured":"St\u00f6rk S et al (2004) Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 15(2):66\u201372","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"10171_CR41","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jama.288.8.980","volume":"288","author":"AD Pradhan","year":"2002","unstructured":"Pradhan AD et al (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women\u2019s Health Initiative observational study. JAMA 288(8):980\u2013987","journal-title":"JAMA"},{"issue":"7255","key":"10171_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","volume":"321","author":"J Danesh","year":"2000","unstructured":"Danesh J et al (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321(7255):199\u2013204","journal-title":"BMJ"},{"issue":"4","key":"10171_CR43","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1210\/en.2010-0627","volume":"152","author":"JP Stice","year":"2011","unstructured":"Stice JP et al (2011) 17\u03b2-Estradiol, aging, inflammation, and the stress response in the female heart. Endocrinology 152(4):1589\u20131598","journal-title":"Endocrinology"},{"issue":"4","key":"10171_CR44","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.cardiores.2005.11.031","volume":"69","author":"Y Xu","year":"2006","unstructured":"Xu Y et al (2006) Estrogen improves cardiac recovery after ischemia\/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res 69(4):836\u2013844","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10171_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/mmr.2015.3394","volume":"12","author":"L Zhong","year":"2015","unstructured":"Zhong L et al (2015) Estrogen receptor \u03b1 mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes. Mol Med Rep 12(1):119\u2013126","journal-title":"Mol Med Rep"},{"issue":"6","key":"10171_CR46","doi-asserted-by":"publisher","first-page":"H2204","DOI":"10.1152\/ajpheart.01219.2005","volume":"290","author":"M Wang","year":"2006","unstructured":"Wang M et al (2006) Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol 290(6):H2204\u2013H2209","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10171_CR47","doi-asserted-by":"publisher","first-page":"H2607","DOI":"10.1152\/ajpheart.01107.2006","volume":"292","author":"D Xing","year":"2007","unstructured":"Xing D et al (2007) Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol 292(6):H2607\u2013H2612","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10171_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.surg.2008.03.009","volume":"144","author":"M Wang","year":"2008","unstructured":"Wang M et al (2008) Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery 144(2):233\u2013238","journal-title":"Surgery"},{"issue":"2","key":"10171_CR49","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.surg.2010.03.011","volume":"148","author":"BR Weil","year":"2010","unstructured":"Weil BR et al (2010) Signaling via GPR30 protects the myocardium from ischemia\/reperfusion injury. Surgery 148(2):436\u2013443","journal-title":"Surgery"},{"issue":"5","key":"10171_CR50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1530\/eje.0.1380482","volume":"138","author":"W Kiess","year":"1998","unstructured":"Kiess W, Gallaher B (1998) Hormonal control of programmed cell death\/apoptosis. Eur J Endocrinol 138(5):482\u2013491","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10171_CR51","first-page":"2315","volume":"12","author":"L Altucci","year":"1996","unstructured":"Altucci L et al (1996) 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene 12(11):2315\u20132324","journal-title":"Oncogene"},{"issue":"25","key":"10171_CR52","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","volume":"115","author":"M Satoh","year":"2007","unstructured":"Satoh M et al (2007) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115(25):3197\u20133204","journal-title":"Circulation"},{"issue":"7","key":"10171_CR53","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.RES.0000144126.57786.89","volume":"95","author":"RD Patten","year":"2004","unstructured":"Patten RD et al (2004) 17beta-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase\/Akt signaling. Circ Res 95(7):692\u2013699","journal-title":"Circ Res"},{"issue":"6","key":"10171_CR54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cbf.1687","volume":"28","author":"CM Liou","year":"2010","unstructured":"Liou CM et al (2010) Effects of 17beta-estradiol on cardiac apoptosis in ovariectomized rats. Cell Biochem Funct 28(6):521\u2013528","journal-title":"Cell Biochem Funct"},{"issue":"7","key":"10171_CR55","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.exger.2006.02.010","volume":"41","author":"R Morkuniene","year":"2006","unstructured":"Morkuniene R, Arandarcikaite O, Borutaite V (2006) Estradiol prevents release of cytochrome c from mitochondria and inhibits ischemia-induced apoptosis in perfused heart. Exp Gerontol 41(7):704\u2013708","journal-title":"Exp Gerontol"},{"key":"10171_CR56","doi-asserted-by":"crossref","unstructured":"Chen BC et al (2018) Estrogen and\/or estrogen receptor \u03b1 inhibits BNIP3-induced apoptosis and autophagy in H9c2 cardiomyoblast cells. Int J Mol Sci\u00a019(5)","DOI":"10.3390\/ijms19051298"},{"key":"10171_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13293-016-0104-8","volume":"7","author":"C Schubert","year":"2016","unstructured":"Schubert C et al (2016) Reduction of apoptosis and preservation of mitochondrial integrity under ischemia\/reperfusion injury is mediated by estrogen receptor \u03b2. Biol Sex Differ 7:53","journal-title":"Biol Sex Differ"},{"issue":"2","key":"10171_CR58","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3892\/mmr.2015.3674","volume":"12","author":"WL Li","year":"2015","unstructured":"Li WL, Xiang W, Ping Y (2015) Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection. Mol Med Rep 12(2):2425\u20132430","journal-title":"Mol Med Rep"},{"issue":"5","key":"10171_CR59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00424-013-1247-7","volume":"465","author":"PA Arias-Loza","year":"2013","unstructured":"Arias-Loza PA, Muehlfelder M, Pelzer T (2013) Estrogen and estrogen receptors in cardiovascular oxidative stress. Pflugers Arch 465(5):739\u2013746","journal-title":"Pflugers Arch"},{"issue":"2","key":"10171_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/01.RES.0000082334.17947.11","volume":"93","author":"K Strehlow","year":"2003","unstructured":"Strehlow K et al (2003) Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 93(2):170\u2013177","journal-title":"Circ Res"},{"issue":"10","key":"10171_CR61","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1074\/jbc.M511024200","volume":"281","author":"JK Kim","year":"2006","unstructured":"Kim JK et al (2006) Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem 281(10):6760\u20136767","journal-title":"J Biol Chem"},{"key":"10171_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.alcohol.2015.11.002","volume":"50","author":"F Yao","year":"2016","unstructured":"Yao F, Abdel-Rahman AA (2016) Estrogen receptor ER\u03b1 plays a major role in ethanol-evoked myocardial oxidative stress and dysfunction in conscious female rats. Alcohol 50:27\u201335","journal-title":"Alcohol"},{"key":"10171_CR63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2018.04.005","volume":"199","author":"H Wang","year":"2018","unstructured":"Wang H et al (2018) G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress. Transl Res 199:39\u201351","journal-title":"Transl Res"},{"issue":"19","key":"10171_CR64","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.968792","volume":"124","author":"L Mosca","year":"2011","unstructured":"Mosca L, Barrett-Connor E, Wenger NK (2011) Sex\/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 124(19):2145\u20132154","journal-title":"Circulation"},{"key":"10171_CR65","doi-asserted-by":"crossref","unstructured":"Rodgers JL et al (2019) Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis\u00a06(2)","DOI":"10.3390\/jcdd6020019"},{"issue":"5","key":"10171_CR66","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/jcmm.13038","volume":"21","author":"MC Kander","year":"2017","unstructured":"Kander MC, Cui Y, Liu Z (2017) Gender difference in oxidative stress: a new look at the mechanisms for cardiovascular diseases. J Cell Mol Med 21(5):1024\u20131032","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10171_CR67","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1139\/y05-151","volume":"84","author":"MP Czubryt","year":"2006","unstructured":"Czubryt MP et al (2006) The role of sex in cardiac function and disease. Can J Physiol Pharmacol 84(1):93\u2013109","journal-title":"Can J Physiol Pharmacol"},{"key":"10171_CR68","doi-asserted-by":"crossref","unstructured":"Donaldson C et al (2009) Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Circ Res\u00a0104(2):265\u201375, 11p following 275","DOI":"10.1161\/CIRCRESAHA.108.190397"},{"issue":"1","key":"10171_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12916-016-0762-8","volume":"15","author":"AC de Kat","year":"2017","unstructured":"de Kat AC et al (2017) Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med 15(1):2","journal-title":"BMC Med"},{"issue":"7","key":"10171_CR70","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1253\/circj.CJ-10-0196","volume":"74","author":"V Regitz-Zagrosek","year":"2010","unstructured":"Regitz-Zagrosek V et al (2010) Sex and gender differences in myocardial hypertrophy and heart failure. Circ J 74(7):1265\u20131273","journal-title":"Circ J"},{"issue":"6","key":"10171_CR71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","volume":"109","author":"E Murphy","year":"2011","unstructured":"Murphy E (2011) Estrogen signaling and cardiovascular disease. Circ Res 109(6):687\u2013696","journal-title":"Circ Res"},{"issue":"20","key":"10171_CR72","doi-asserted-by":"publisher","first-page":"19704","DOI":"10.1074\/jbc.M501244200","volume":"280","author":"X Guo","year":"2005","unstructured":"Guo X et al (2005) Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 280(20):19704\u201319710","journal-title":"J Biol Chem"},{"issue":"5554","key":"10171_CR73","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.1065250","volume":"295","author":"Y Zhu","year":"2002","unstructured":"Zhu Y et al (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta. Science 295(5554):505\u2013508","journal-title":"Science"},{"issue":"2","key":"10171_CR74","doi-asserted-by":"publisher","first-page":"E283","DOI":"10.1073\/pnas.1322057111","volume":"111","author":"M Adlanmerini","year":"2014","unstructured":"Adlanmerini M et al (2014) Mutation of the palmitoylation site of estrogen receptor \u03b1 in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A 111(2):E283\u2013E290","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10171_CR75","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/en.2008-0133","volume":"149","author":"A Pedram","year":"2008","unstructured":"Pedram A et al (2008) Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Endocrinology 149(7):3361\u20133369","journal-title":"Endocrinology"},{"issue":"1","key":"10171_CR76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1677\/JOE-07-0130","volume":"194","author":"SJ Sangaralingham","year":"2007","unstructured":"Sangaralingham SJ, Tse MY, Pang SC (2007) Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice. J Endocrinol 194(1):143\u2013152","journal-title":"J Endocrinol"},{"key":"10171_CR77","doi-asserted-by":"crossref","unstructured":"Tsai CY et al (2017) E2\/ER \u03b2 inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling. PLoS One\u00a012(9):e0184153","DOI":"10.1371\/journal.pone.0184153"},{"issue":"4","key":"10171_CR78","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.cardiores.2005.04.035","volume":"67","author":"T Pelzer","year":"2005","unstructured":"Pelzer T et al (2005) The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Cardiovasc Res 67(4):604\u2013612","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10171_CR79","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1161\/01.ATV.0000223344.11128.23","volume":"26","author":"FA Babiker","year":"2006","unstructured":"Babiker FA et al (2006) Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. Arterioscler Thromb Vasc Biol 26(7):1524\u20131530","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10171_CR80","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.lfs.2005.04.077","volume":"78","author":"CH Wu","year":"2005","unstructured":"Wu CH et al (2005) 17beta-estradiol reduces cardiac hypertrophy mediated through the up-regulation of PI3K\/Akt and the suppression of calcineurin\/NF-AT3 signaling pathways in rats. Life Sci 78(4):347\u2013356","journal-title":"Life Sci"},{"key":"10171_CR81","doi-asserted-by":"crossref","unstructured":"Westphal C et al (2012) Effects of estrogen, an ER\u03b1 agonist and raloxifene on pressure overload induced cardiac hypertrophy. PLoS One\u00a07(12):e50802","DOI":"10.1371\/journal.pone.0050802"},{"issue":"4","key":"10171_CR82","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/cvr\/cvm081","volume":"77","author":"V Jazbutyte","year":"2008","unstructured":"Jazbutyte V et al (2008) Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 77(4):774\u2013781","journal-title":"Cardiovasc Res"},{"key":"10171_CR83","doi-asserted-by":"crossref","unstructured":"Di Mattia RA et al (2020)\u00a0The activation of the G protein-coupled estrogen receptor (GPER) prevents and regresses cardiac hypertrophy. Life Sci\u00a0242:117211","DOI":"10.1016\/j.lfs.2019.117211"},{"issue":"1\u20132","key":"10171_CR84","first-page":"135","volume":"405","author":"H Wang","year":"2015","unstructured":"Wang H et al (2015) Activation of GPR30 inhibits cardiac fibroblast proliferation. Mol Cell Biochem 405(1\u20132):135\u2013148","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10171_CR85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/ijbs.28304","volume":"15","author":"H Pei","year":"2019","unstructured":"Pei H et al (2019) G protein-coupled estrogen receptor 1 inhibits Angiotensin II-induced Cardiomyocyte Hypertrophy via the regulation of PI3K-Akt-mTOR signalling and autophagy. Int J Biol Sci 15(1):81\u201392","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10171_CR86","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tibs.2010.07.003","volume":"35","author":"E Verdin","year":"2010","unstructured":"Verdin E et al (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35(12):669\u2013675","journal-title":"Trends Biochem Sci"},{"issue":"10","key":"10171_CR87","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1161\/01.RES.0000267723.65696.4a","volume":"100","author":"RR Alcendor","year":"2007","unstructured":"Alcendor RR et al (2007) Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ Res 100(10):1512\u20131521","journal-title":"Circ Res"},{"issue":"4","key":"10171_CR88","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer X et al (2013) An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int J Cardiol 168(4):3160\u20133172","journal-title":"Int J Cardiol"},{"issue":"3","key":"10171_CR89","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","volume":"25","author":"HC Chang","year":"2014","unstructured":"Chang HC, Guarente L (2014) SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 25(3):138\u2013145","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"10171_CR90","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.M109.090266","volume":"285","author":"M Tanno","year":"2010","unstructured":"Tanno M et al (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285(11):8375\u20138382","journal-title":"J Biol Chem"},{"issue":"1","key":"10171_CR91","doi-asserted-by":"publisher","first-page":"43","DOI":"10.18632\/aging.100107","volume":"2","author":"M Vinciguerra","year":"2009","unstructured":"Vinciguerra M et al (2009) Local IGF-1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging (Albany NY) 2(1):43\u201362","journal-title":"Aging (Albany NY)"},{"issue":"21","key":"10171_CR92","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.110.958033","volume":"122","author":"CP Hsu","year":"2010","unstructured":"Hsu CP et al (2010) Silent information regulator 1 protects the heart from ischemia\/reperfusion. Circulation 122(21):2170\u20132182","journal-title":"Circulation"},{"issue":"3","key":"10171_CR93","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2008.11.110","volume":"378","author":"CJ Chen","year":"2009","unstructured":"Chen CJ et al (2009) Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem Biophys Res Commun 378(3):389\u2013393","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10171_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/cvr\/cvn224","volume":"80","author":"QJ Zhang","year":"2008","unstructured":"Zhang QJ et al (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80(2):191\u2013199","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10171_CR95","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.mad.2009.06.004","volume":"130","author":"A Csiszar","year":"2009","unstructured":"Csiszar A et al (2009) Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev 130(8):518\u2013527","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10171_CR96","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1474-9726.2011.00766.x","volume":"11","author":"M Vinciguerra","year":"2012","unstructured":"Vinciguerra M et al (2012) mIGF-1\/JNK1\/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11(1):139\u2013149","journal-title":"Aging Cell"},{"issue":"1\u20134","key":"10171_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000104152","volume":"20","author":"A Furukawa","year":"2007","unstructured":"Furukawa A et al (2007) H2O2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD+ depletion. Cell Physiol Biochem 20(1\u20134):45\u201354","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10171_CR98","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbrc.2010.01.080","volume":"393","author":"G Arunachalam","year":"2010","unstructured":"Arunachalam G et al (2010) SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol. Biochem Biophys Res Commun 393(1):66\u201372","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10171_CR99","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.bcp.2012.06.031","volume":"84","author":"H Yao","year":"2012","unstructured":"Yao H, Rahman I (2012) Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem Pharmacol 84(10):1332\u20131339","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10171_CR100","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvq376","volume":"90","author":"A Planavila","year":"2011","unstructured":"Planavila A et al (2011) Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res 90(2):276\u2013284","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10171_CR101","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2337\/db11-0616","volume":"60","author":"MP Gillum","year":"2011","unstructured":"Gillum MP et al (2011) SirT1 regulates adipose tissue inflammation. Diabetes 60(12):3235\u20133245","journal-title":"Diabetes"},{"issue":"1","key":"10171_CR102","first-page":"973","volume":"18","author":"B Yang","year":"2018","unstructured":"Yang B et al (2018) Dioscin protects against coronary heart disease by reducing oxidative stress and inflammation via Sirt1\/Nrf2 and p38 MAPK pathways. Mol Med Rep 18(1):973\u2013980","journal-title":"Mol Med Rep"},{"issue":"11","key":"10171_CR103","first-page":"6390","volume":"24","author":"J Xie","year":"2020","unstructured":"Xie J et al (2020) Kallistatin alleviates heart failure in rats by inhibiting myocardial inflammation and apoptosis via regulating sirt1. Eur Rev Med Pharmacol Sci 24(11):6390\u20136399","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"10171_CR104","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","volume":"13","author":"HY Cohen","year":"2004","unstructured":"Cohen HY et al (2004) Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13(5):627\u2013638","journal-title":"Mol Cell"},{"issue":"9","key":"10171_CR105","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0962-8924(02)02342-5","volume":"12","author":"J Smith","year":"2002","unstructured":"Smith J (2002) Human Sir2 and the \u201csilencing\u201d of p53 activity. Trends Cell Biol 12(9):404\u2013406","journal-title":"Trends Cell Biol"},{"issue":"19","key":"10171_CR106","doi-asserted-by":"publisher","first-page":"10794","DOI":"10.1073\/pnas.1934713100","volume":"100","author":"HL Cheng","year":"2003","unstructured":"Cheng HL et al (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 100(19):10794\u201310799","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10171_CR107","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/01.RES.0000147557.75257.ff","volume":"95","author":"RR Alcendor","year":"2004","unstructured":"Alcendor RR et al (2004) Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res 95(10):971\u2013980","journal-title":"Circ Res"},{"issue":"52","key":"10171_CR108","doi-asserted-by":"publisher","first-page":"43121","DOI":"10.1074\/jbc.M506162200","volume":"280","author":"JB Pillai","year":"2005","unstructured":"Pillai JB et al (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity. J Biol Chem 280(52):43121\u201343130","journal-title":"J Biol Chem"},{"issue":"3","key":"10171_CR109","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1515\/BC.2008.032","volume":"389","author":"CP Hsu","year":"2008","unstructured":"Hsu CP et al (2008) Sirt1 protects the heart from aging and stress. Biol Chem 389(3):221\u2013231","journal-title":"Biol Chem"},{"key":"10171_CR110","doi-asserted-by":"crossref","unstructured":"Han X et al (2020) Resveratrol protects H9c2 cells against hypoxia-induced apoptosis through miR-30d-5p\/SIRT1\/NF-\u03baB axis. J Biosci\u00a045","DOI":"10.1007\/s12038-020-9997-9"},{"issue":"1","key":"10171_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.11.005","volume":"49","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K (2005) Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer\u2019s disease. Brain Res Brain Res Rev 49(1):1\u201321","journal-title":"Brain Res Brain Res Rev"},{"issue":"8","key":"10171_CR112","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1161\/CIRCRESAHA.111.246470","volume":"110","author":"L Fontana","year":"2012","unstructured":"Fontana L, Vinciguerra M, Longo VD (2012) Growth factors, nutrient signaling, and cardiovascular aging. Circ Res 110(8):1139\u20131150","journal-title":"Circ Res"},{"issue":"6","key":"10171_CR113","doi-asserted-by":"publisher","first-page":"402","DOI":"10.18632\/aging.100464","volume":"4","author":"G Bolasco","year":"2012","unstructured":"Bolasco G et al (2012) Cardioprotective mIGF-1\/SIRT1 signaling induces hypertension, leukocytosis and fear response in mice. Aging (Albany NY) 4(6):402\u2013416","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10171_CR114","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","volume":"11","author":"D Harman","year":"1956","unstructured":"Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11(3):298\u2013300","journal-title":"J Gerontol"},{"issue":"3","key":"10171_CR115","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/cvr\/cvp337","volume":"85","author":"J Gracia-Sancho","year":"2010","unstructured":"Gracia-Sancho J et al (2010) Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype. Cardiovasc Res 85(3):514\u2013519","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10171_CR116","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.3390\/ijms14023834","volume":"14","author":"A Salminen","year":"2013","unstructured":"Salminen A, Kaarniranta K, Kauppinen A (2013) Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int J Mol Sci 14(2):3834\u20133859","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10171_CR117","doi-asserted-by":"publisher","first-page":"5289","DOI":"10.1074\/jbc.M110.163667","volume":"286","author":"S Xiong","year":"2011","unstructured":"Xiong S et al (2011) FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J Biol Chem 286(7):5289\u20135299","journal-title":"J Biol Chem"},{"issue":"1","key":"10171_CR118","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tcm.2012.01.005","volume":"21","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Sadoshima J (2011) Protection of the heart against ischemia\/reperfusion by silent information regulator 1. Trends Cardiovasc Med 21(1):27\u201332","journal-title":"Trends Cardiovasc Med"},{"key":"10171_CR119","doi-asserted-by":"crossref","unstructured":"Rajendran R et al (2011) Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol\u00a02011:368276","DOI":"10.1155\/2011\/368276"},{"issue":"7","key":"10171_CR120","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen A, Hyttinen JM, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-\u03baB signaling and inflammation: impact on healthspan and lifespan. J Mol Med (Berl) 89(7):667\u2013676","journal-title":"J Mol Med (Berl)"},{"issue":"7","key":"10171_CR121","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1016\/S0021-9258(17)37600-7","volume":"269","author":"QW Xie","year":"1994","unstructured":"Xie QW, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-kappa B\/Rel in induction of nitric oxide synthase. J Biol Chem 269(7):4705\u20134708","journal-title":"J Biol Chem"},{"issue":"37","key":"10171_CR122","doi-asserted-by":"publisher","first-page":"14855","DOI":"10.1073\/pnas.0704329104","volume":"104","author":"I Mattagajasingh","year":"2007","unstructured":"Mattagajasingh I et al (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 104(37):14855\u201314860","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10171_CR123","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1101\/gad.435107","volume":"21","author":"M Potente","year":"2007","unstructured":"Potente M et al (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21(20):2644\u20132658","journal-title":"Genes Dev"},{"issue":"1\u20133","key":"10171_CR124","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0014-5793(03)01444-3","volume":"556","author":"J Sakamoto","year":"2004","unstructured":"Sakamoto J et al (2004) Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett 556(1\u20133):281\u2013286","journal-title":"FEBS Lett"},{"issue":"9","key":"10171_CR125","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1074\/jbc.M609554200","volume":"282","author":"M Tanno","year":"2007","unstructured":"Tanno M et al (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282(9):6823\u20136832","journal-title":"J Biol Chem"},{"key":"10171_CR126","doi-asserted-by":"crossref","unstructured":"Sundaresan NR et al (2011) The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci Signal\u00a04(182):ra46","DOI":"10.1126\/scisignal.2001465"},{"issue":"10","key":"10171_CR127","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1161\/01.RES.0000269326.37165.3d","volume":"100","author":"D Sedding","year":"2007","unstructured":"Sedding D, Haendeler J (2007) Do we age on Sirt1 expression? Circ Res 100(10):1396\u20131398","journal-title":"Circ Res"},{"issue":"3","key":"10171_CR128","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.bbrc.2012.11.132","volume":"430","author":"B Geng","year":"2013","unstructured":"Geng B et al (2013) PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1. Biochem Biophys Res Commun 430(3):944\u2013950","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10171_CR129","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3945\/jn.109.115006","volume":"140","author":"P Wojciechowski","year":"2010","unstructured":"Wojciechowski P et al (2010) Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. J Nutr 140(5):962\u2013968","journal-title":"J Nutr"},{"issue":"6","key":"10171_CR130","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","volume":"1865","author":"S Li","year":"2019","unstructured":"Li S et al (2019) Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1. Biochim Biophys Acta Mol Basis Dis 1865(6):1241\u20131252","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"9","key":"10171_CR131","first-page":"2757","volume":"22","author":"HW Dong","year":"2018","unstructured":"Dong HW, Zhang LF, Bao SL (2018) AMPK regulates energy metabolism through the SIRT1 signaling pathway to improve myocardial hypertrophy. Eur Rev Med Pharmacol Sci 22(9):2757\u20132766","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10171_CR132","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/156720210791184899","volume":"7","author":"J Hou","year":"2010","unstructured":"Hou J et al (2010) Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res 7(2):95\u2013112","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"10171_CR133","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/156720211796558069","volume":"8","author":"J Hou","year":"2011","unstructured":"Hou J et al (2011) Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress. Curr Neurovasc Res 8(3):220\u2013235","journal-title":"Curr Neurovasc Res"},{"issue":"6","key":"10171_CR134","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.bcp.2004.04.031","volume":"68","author":"R Margueron","year":"2004","unstructured":"Margueron R et al (2004) Histone deacetylase inhibition and estrogen signalling in human breast cancer cells. Biochem Pharmacol 68(6):1239\u20131246","journal-title":"Biochem Pharmacol"},{"issue":"31","key":"10171_CR135","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1038\/sj.onc.1208662","volume":"24","author":"G Reid","year":"2005","unstructured":"Reid G et al (2005) Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor alpha, in response to deacetylase inhibition by valproic acid and trichostatin A. Oncogene 24(31):4894\u20134907","journal-title":"Oncogene"},{"issue":"3","key":"10171_CR136","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/carcin\/bgp308","volume":"31","author":"Y Yao","year":"2010","unstructured":"Yao Y et al (2010) Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling. Carcinogenesis 31(3):382\u2013387","journal-title":"Carcinogenesis"},{"key":"10171_CR137","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fendo.2018.00552","volume":"9","author":"S Liarte","year":"2018","unstructured":"Liarte S, Alonso-Romero JL, Nicol\u00e1s FJ (2018) SIRT1 and estrogen signaling cooperation for breast cancer onset and progression. Front Endocrinol (Lausanne) 9:552","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10171_CR138","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bph.12290","volume":"170","author":"DS Bendale","year":"2013","unstructured":"Bendale DS et al (2013) 17-\u03b2 Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1\/AMPK\/H3 acetylation. Br J Pharmacol 170(4):779\u2013795","journal-title":"Br J Pharmacol"},{"issue":"Pt 1","key":"10171_CR139","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1113\/jphysiol.2006.109389","volume":"574","author":"JR Dyck","year":"2006","unstructured":"Dyck JR, Lopaschuk GD (2006) AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574(Pt 1):95\u2013112","journal-title":"J Physiol"},{"issue":"Pt 18","key":"10171_CR140","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1113\/jphysiol.2011.211219","volume":"589","author":"AJ Donato","year":"2011","unstructured":"Donato AJ et al (2011) SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans. J Physiol 589(Pt 18):4545\u20134554","journal-title":"J Physiol"},{"issue":"6","key":"10171_CR141","first-page":"2641","volume":"8","author":"Z Meng","year":"2016","unstructured":"Meng Z et al (2016) Resveratrol attenuated estrogen-deficient-induced cardiac dysfunction: role of AMPK, SIRT1, and mitochondrial function. Am J Transl Res 8(6):2641\u20132649","journal-title":"Am J Transl Res"},{"issue":"4","key":"10171_CR142","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/cns.12686","volume":"23","author":"JM Guo","year":"2017","unstructured":"Guo JM et al (2017) SIRT1-dependent AMPK pathway in the protection of estrogen against ischemic brain injury. CNS Neurosci Ther 23(4):360\u2013369","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"10171_CR143","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10522-009-9221-7","volume":"10","author":"A Elbaz","year":"2009","unstructured":"Elbaz A, Rivas D, Duque G (2009) Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL\/6J mice. Biogerontology 10(6):747\u2013755","journal-title":"Biogerontology"},{"issue":"2","key":"10171_CR144","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1124\/jpet.107.134882","volume":"325","author":"KA Rasbach","year":"2008","unstructured":"Rasbach KA, Schnellmann RG (2008) Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 325(2):536\u2013543","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10171_CR145","doi-asserted-by":"publisher","first-page":"6654","DOI":"10.1158\/0008-5472.CAN-11-1446","volume":"71","author":"S Elangovan","year":"2011","unstructured":"Elangovan S et al (2011) SIRT1 is essential for oncogenic signaling by estrogen\/estrogen receptor \u03b1 in breast cancer. Cancer Res 71(21):6654\u20136664","journal-title":"Cancer Res"},{"key":"10171_CR146","unstructured":"Tao Z (2019)\u00a0Estrogen signaling interacts with Sirt1 in adipocyte autophagy\u00a0Virginia Tech"},{"issue":"7","key":"10171_CR147","doi-asserted-by":"publisher","first-page":"e1834","DOI":"10.1038\/cddis.2015.201","volume":"6","author":"MF Santolla","year":"2015","unstructured":"Santolla MF et al (2015) SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Cell Death Dis 6(7):e1834\u2013e1834","journal-title":"Cell Death Dis"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10171-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10171-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T17:31:44Z","timestamp":1675704704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10171-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":147,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10171"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10171-0","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"7 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that there are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}